[HTML][HTML] Determinants of human papillomavirus vaccine uptake by adult women attending cervical cancer screening in 9 European countries

C Robles, L Bruni, A Acera, JC Riera, L Prats… - American Journal of …, 2021 - Elsevier
Introduction Human papillomavirus–vaccinated cohorts, irrespective of age, will likely
reduce their subsequent screening requirements, thus opening opportunities for global cost …

The impact of HPV vaccination beyond cancer prevention: effect on pregnancy outcomes

S Yuill, LS Velentzis, M Smith, S Egger… - Human vaccines & …, 2021 - Taylor & Francis
While the benefits of human papillomavirus (HPV) vaccination relating to cervical cancer
prevention have been widely documented, recent published evidence is suggestive of an …

Rates of oropharyngeal cancer continue to rise steeply amongst Australian men

KM Fan, S Sprague, P Zhang, A Ariyawardana… - Oral …, 2023 - Wiley Online Library
Objective The objective was to analyse the trends in the incidence of oropharyngeal cancers
(OPC) across Australia from 1982 to 2017 with implications for prevention. Methods Data …

Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy

F Carozzi, D Puliti, C Ocello, PS Anastasio… - BMC infectious …, 2018 - Springer
Background A large free-of-charge quadrivalent HPV (qHPV) vaccination program, covering
four cohorts annually (women 11, 14, 17 and 24 years), has been implemented in Basilicata …

Human papillomavirus vaccination and cervical cytology outcomes among urban low-income minority females

AM Hofstetter, DC Ompad, MS Stockwell… - JAMA …, 2016 - jamanetwork.com
Importance The quadrivalent human papillomavirus (HPV) vaccine was licensed for use in 9-
through 26-year-old females in 2006. Postlicensure studies in Australia, Denmark, and …

Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women

Y Shiko, R Konno, H Konishi, C Sauvaget… - BMC Infectious …, 2020 - Springer
Background Although more than 10 years have passed since HPV vaccination was
implemented, first as an interim programme (Emergent vaccine promotion programme) in …

[PDF][PDF] Immunisation coverage annual report, 2015.

BP Hull, AJ Hendry, AD Aditi Dey, FH Beard… - 2019 - health.gov.au
This 9th annual immunisation coverage report shows data for 2015 derived from the
Australian Childhood Immunisation Register and the National Human Papillomavirus (HPV) …

Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014 …

EPF Chow, SN Tabrizi, CK Fairley, R Wigan… - Vaccine, 2019 - Elsevier
Background Australia introduced a school-based human papillomavirus (HPV) vaccination
program for females aged 12–13 years in 2007, with a three-year catch-up to age 26; and for …

Prophylactic vaccination against human papillomaviruses to prevent vulval and vaginal cancer and their precursors

L Xu, A Selk, SM Garland, F Bogliatto… - Expert review of …, 2019 - Taylor & Francis
Introduction: Safety and efficacy of prophylactic HPV vaccines against HPV infection and
associated cervical cancers and precursors is well documented in the literature; however …

Knowledge and attitudes of mothers toward HPV vaccination: A cross-sectional study in Kazakhstan

A Babi, T Issa, A Issanov, S Akhanova… - Women's …, 2023 - journals.sagepub.com
Background: Although recommended for all member states of World Health Organization,
there is no national human papillomavirus vaccination program in Kazakhstan. Furthermore …